Roger J. Pomerantz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Roger J. Pomerantz
Roger J. Pomerantz is recorded as CEO at Seres Therapeutics, Inc. (MCRB). The proxy statement of Seres Therapeutics, Inc. reports total compensation of $3,018,060 for Roger J. Pomerantz in fiscal 2018, including a base salary of $595,000.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Seres Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Marella Thorell CEO, CFO, Chief Accounting Officer
- Richard N. Kender CEO, Chairman, Board Member
- Kelly Brady COO
- Kelly Brady, M.S. COO
- David S. Ege CTO
- David Arkowitz Chief Accounting Officer
- Eric Shaff Chief Accounting Officer
- Claire Fraser, Ph.D. Board Member
- Claire M. Fraser, Ph.D. Board Member
- Dennis A. Ausiello Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2018 | Seres Therapeutics, Inc. (MCRB) | Former President and Chief Executive Officer | $595,000 | $3,018,060 |
Recent activity
No call appearances or filed executive changes recorded yet.